Post by chaosonline on Apr 22, 2009 17:24:16 GMT -5
From Here: www.o-wm.com/article/7067
Recurring and Antimicrobial-Resistant Infections: Considering the Potential Role of Biofilms in Clinical Practice
author: Donald E. Saye, DPM
A biofilm colony is a complex, structured, interdependent community of micro-organisms enclosed in a self-produced polymeric matrix (the biofilm, frequently referred to as glycocalyx or slime). Biofilm is adherent to inert and living surfaces that have sufficient moisture and/or nutrients to sustain its survival.1,2 Like other infections, the biofilm colony may be a single species or a mixture of species of bacteria and/or fungi and may be different strains of the same species.3-7
Biofilm formation is not uncommon or limited to a small number of micro-organisms or tissues.1,8,9 The Centers for Disease Control and Prevention (CDC) has suggested that biofilms account for 80% of human infections.10 Alam et al11 screened 111 cultures of pus, exudate, joint aspirate, and blood obtained aseptically from cases of osteomyelitis and septic arthritis. Glycocalyx was found in 76.3% of isolates of Staphylococcus aureus, 57.1% of S. epidermidis, 50% of Pseudomonas aeruginosa, and 75% of Escherichia coli. Gristina et al12 examined tissues from biomaterials and prosthesis-related infection in 25 surgical patients in a general hospital setting and found that 76% of the causative bacteria grew in biofilms; 17 of these infections were associated with orthopaedic prostheses, 59% of which were in biofilms. However, organisms in biofilms do not always produce an infectious disease and are not always harmful. Current knowledge of biofilm development, resistance of micro-organisms to antibiotics and biocides, and issues related to culturing micro-organisms in biofilms is summarized to help clinicians improve clinical outcomes in soft tissue and bone infections and the treatment of wounds. A glossary of relevant terms (see “Glossary of Terms”) has been provided.
Biofilm Development
Biofilms form on wet or moist surfaces. Biofilm formation begins immediately upon micro-organism contact with biologic tissue or a medical device4,13–21 (see Figure 1).
Biologic tissue. Initially, organic molecules in tissue fluids form a layer on the tissues or medical device called a conditioning film. The different strains or species of micro-organisms in the immediate vicinity co-aggregate22; subsequently, cell-to-cell adhesion to the conditioning film occurs.13,23–25 With continued adhesion of micro-organisms, a multilayered colony of cells is formed. The colony of micro-organisms anchors firmly and is surrounded with a self-produced, glue-like slime matrix, comprised primarily of exopolysaccharide and some lipids, proteins, and nucleic acids.26–33 Once the colony is anchored, the process becomes irreversible.
The biofilm has a rough, irregular surface that contains many individual colonies of non-uniform, mushroom-shaped or finger-like columns surrounded by fluid-filled channels in which nutrients, enzymes, and waste products circulate.34 Biofilms produced under different conditions differ in their cellular morphology and matrix content.35 The biofilm’s strength of attachment depends on its adhesion to the conditioning film.13,36 Human blood has been shown to enhance development of Gram-positive and Gram-negative bacterial biofilms37; heparin has been shown to promote S. aureus biofilm formation.38
A mature biofilm may take a few hours or several weeks to fully develop. In one study,39 a methicillin-resistant S. aureus biofilm was found to be six cells thick and covered 10% of the surface of a silastic catheter after 2 hours. The biofilm may entrap minerals — mineral build-up is associated with catheter blockage.40
Biofilm colonies form on traumatized or compromised living tissues and nonviable necrotic tissues such as burns,8 wounds and skin ulcers,41,42 and exposed or damaged tendon.43 Impetigo and furuncles have been identified as ideal surfaces for biofilm formation by contaminating and colonizing bacteria.44 Acute and chronic otitis media, chronic tonsillitis, osteomyelitis, bone fragments or sequestra, and exposed bone are susceptible tissues for biofilm formation.42,45,46 Biofilms are found on heart valves, dental enamel, intestinal mucosa,1 between toes and in armpits,47 and are associated with rheumatoid arthritis48 and genitourinary disease.49,50
Medical devices. Because metal plates or screws, artificial joints, indwelling catheters, internal fixation devices, sutures,8,51 and other internal medical devices may be wet or moist surfaces, they are subject to biofilm formation. Biofilms also form on bone cement, even in the presence of antibiotics, including gentamicin52–55; they use these surfaces as a foundation to spread into adjacent tissues and form new colonies of biofilm-protected micro-organisms.12
The effect of strains. Biofilm formation is strain dependent.56,57 Different strains of the same bacteria may develop biofilms of different consistencies. Generally, older biofilms are more developed, provide more protection, and their micro-organisms are more resistant to biocides, antibacterials, and conventional culturing than younger colonies.13,58
Gene expression. Gene expression plays an important role in biofilm production, pathogenicity, and virulence.59–62 High population or critical cell population density-dependent processes known as quorum sensing provide bacteria the ability to communicate, coordinate, and respond to gene expression via signaling molecules once a threshold population density has been reached.63,64 Bacteria produce and detect signaling molecules (autoinducers) and use them to communicate cell-to-cell and coordinate gene expression (behavior). When bacteria multiply to a high population density (a quorum) and produce enough autoinducer (reach and sense a threshold level), the group responds by coordinating its gene expression with a population-wide gene expression, coordinating the behavior of the entire community of bacteria.65 For example, bacteria may colonize a wound, but they do not become a pathogenic-causing disease until they reach a certain population density such as 105 bacteria per gram of tissue. Micro-organisms use quorum sensing for diverse genetic cellular processes, including biofilm formation.57,64,66
Survival. Micro-organisms within the biofilm may be in a low metabolic state but remain fit and able to survive under stress on a minimal amount of nutrients. An anerobic layer of bacteria may develop beneath the aerobic layer where oxygen levels are low enough to sustain their survival.
Infection. Bacteria in biofilms are commonly responsible for recurring infections after repeated trials of antibiotics.1,67 The micro-organisms may be slow to produce clinical symptoms and may remain dormant for weeks or years before causing local or systemic signs and symptoms of infection. Because the biofilm is a dynamic environment,30,32,68,69 the integrity of part or all of the biofilm may fail at any time. The micro-organisms no longer within the biofilm may quickly multiply and disperse, causing rapid increases in bacterial counts and random showers of bacteria.70,71
Detachment or separation and dispersal of bacteria from the biofilm, such as after an injury, can act as a nidus of infection.72,73 The micro-organisms that are now planktonic, or free-floating, may cause a bacteremia or a chronic recurring infection such as osteomyelitis, cellulitis, sinusitis, or urinary tract infections. Biofilm colonies are often polymicrobial — the same bacteria may not always cause the recurrent infection.
Biofilm Resistance
Biofilms are complex and depending on a variety of factors, including bacterial strain and dosage of the antibiotic, may decrease or may have little or no impact on the effectiveness of antimicrobials.74–83 Appropriate antibiotics act on the bacteria outside the biofilm while the same species of bacteria inside the biofilm are effectively protected from most antimicrobials and the host’s defense mechanisms.
MBC concentration. Bacteria inside the biofilm have a much higher minimum bactericidal concentration (MBC) than the same strain of bacteria outside the biofilm.72,77,84,85 Bacteria within a biofilm may require levels of antibiotics up to 5,000 times the MBC to kill all of their biofilm-protected bacteria compared to MBC levels that kill free-floating cells of the same strain.73 In a microbiological survey of automated water systems, Dreeszen86 reported bacteria in biofilms 3,000 times more resistant to free chlorine than the planktonic bacteria. This may overstate the clinical problem since most human infections are treated successfully with antimicrobials. However, achievable safe therapeutic levels of most antibiotics have been shown to be ineffective in killing most biofilm-protected bacteria.8,81,87
The mechanism of resistance is complex and remains unclear but is known to be multifactorial and varies with the species and the strain of the micro-organism. Resistance appears to depend on multicellular synergistic behavior,88 the physiological characteristics of the biofilm itself, the age of the biofilm, altered physiology of cells within the biofilm, and phenotypic changes in the cells within the biofilm.4,9,89–91
Synergistic behavior. Rather than conforming to individual, single-species bacterial behavior, micro-organisms in a biofilm, whether or not mixed species, communicate between and among the same and different species by cell-to-cell signaling, interacting with each other and their environment, sharing resources, and exhibiting multicellular synergistic behavior with common goals similar to a community.92–96 One of the goals of these communities is to lessen the effects of biocides and antimicrobials. This behavior cannot be achieved by individual single-species micro-organisms.32,92–94,97–101
Charge and age. Other physiological characteristics of the biofilm contribute to resistance. The biofilm has a negative charge and may restrict diffusion of positive-charged antibiotics such as aminoglycosides. In general, older biofilms are more developed, thicker, and more viscous.58,102–104 The biofilm may act as a mechanical barrier, resisting penetration or slowing the rate of diffusion of the biocide or antimicrobial; hence, diminishing its effect.105 Only those bacteria found in the outer layer of the biofilm may be exposed to the antimicrobials and antigens. In addition, antibiotic penetration is agent- and organism-specific.
Altered physiology. The biofilm may dilute, bind, or entrap all or part of the antimicrobial, preventing therapeutic levels of antibiotics, antibodies, or phagocytes from reaching the bacteria within the biofilm,102,106–113 limiting therapy effectiveness. Slow diffusion through the biofilm allows more time for the bacteria within the biofilm to provide a community-wide defense response to weaken the effect of the incoming antimicrobials.114
When the antimicrobials are able to penetrate the biofilm and kill the bacteria within, a few resistant strains may survive. These surviving bacteria (persisters) may be intracellular and are resistant to further antibiotic treatment.115,116 When antibiotic therapy is discontinued, the persisters reform the biofilm.
Growth rate. Bacteria in biofilms are associated with slow growth rates,117 especially bacteria in the deeper layers of the biofilm where nutrients may have difficulty penetrating the biofilm and waste product excretion may be slow.1,77,118–120 Many antibiotics (eg, cephalosporins) are less effective against slowly multiplying bacteria.
Colony size. Biofilm colonies are generally too large for phagocytes to engulf them. The biofilm may resist penetration by the phagocytes, reducing their effectiveness. Chemotactic activities of phagocytes may be inhibited by the biofilm.8,52,113,121,122
Gene expression. Gene expression plays an important role in pathogenicity and virulence of micro-organisms in the biofilm.123 The phenotypic changes that occur in the micro-organisms within the biofilm make them resistant to antimicrobial treatment and to the host’s immune response.89,124,125 Micro-organisms in biofilms often will express more virulent phenotypes than the same planktonic strain.59,123,126,127 The bacterial cell has a small number of target sites for antibiotics. It is theorized that some cells in the biofilm, using different genes than the planktonic bacteria, phenotypically alter these target sites to protect themselves.124,128–131 Quorum-sensing and sigma factor systems that signal bacteria to change their biochemistry regulate many of these gene expressions. Biocides have a much larger number of target sites, making it difficult for micro-organisms to develop resistance to such compounds; however, bacteria in the biofilm can and do resist biocides.
Biofilm Cultures
Micro-organisms grow almost everywhere but fewer than 10% can be grown outside their environment in the laboratory.132–137 Accurate identification and determination of micro-organism antibiotic sensitivities are important for the selection of appropriate therapy. However, micro-organisms within biofilm resist conventional culturing methods.8,73,138,139 The same strain of micro-organism outside the biofilm and micro-organisms released when the biofilm is disrupted lose their protection and may be cultured using conventional culturing methods.
Biofilm colonies are dynamic and frequently changing.30 A biofilm colony containing many bacteria may detach intact, sometimes separated by an injury, and grow as a single colony on or in culture media.74 Because these colonies may be slow growing,117 the cultures may be discarded before the organisms have been identified. When biofilm colonies are cultured, contaminating or colonizing bacteria may dominate the culture and the pathogenic organism, if grown at all, may never be identified.12
The micro-organisms that separate from the biofilm and are identified by conventional culturing methods may not be representative of the types, numbers, or pathogenicity of bacteria within the biofilm.8,140 Instead of identifying the pathogenic bacteria in the biofilm causing the infection, conventional cultures may identify the non-pathogenic planktonic bacteria; therefore, failure to disrupt the biofilm may result in a falsely sterile culture or the recovery of the non-pathogenic planktonic bacteria colonizing or contaminating the tissues. Sensitivity reports for these bacteria may lead to a false clinical interpretation. Consequently, long-established conventional methods of collecting micro-organisms from bone, blood, joint effusion, swabs, or soft tissue samples in sufficient numbers to be identified in cultures may be thwarted by the properties of the biofilm.12
Ultrasonic oscillation (sonication) of biofilm culture specimens using low-energy, high frequency sound waves has been shown to disrupt the biofilm.104,141,142 Once the biofilm is disrupted or the micro-organisms leave the biofilm, the micro-organisms revert back to their original phenotype and can be identified using conventional culture techniques. Another method to identify bacteria is a culture-based independent approach to detect and identify micro-organisms in a biofilm-protected environment.135,136,143,144 These non-conventional methods are not readily available to the clinician.145,146
Treatment
The treatment of biofilm-related infections is complex and beyond the scope of this paper. In addition, definitive treatment for biofilm infections for the most part remains in the sphere of research studies that have yet to reach clinical practice. Much of the data come from animal or laboratory models or industrial use and vary widely in design. Because research studies are performed under ideal conditions that are much different from the conditions encountered in the human body, they are not necessarily clinically useful. Furthermore, the biofilm and the bacteria in the biofilm are dynamic and constantly changing. Because of the complexity of this issue, the treatment of biofilm infections remains poorly understood and under investigation.
Discussion
Infection is rare considering that on a daily basis the human body coexists in a symbiotic relationship with 1014 micro-organisms from a countless number of vectors.147 The development of an infectious disease and the virulence of the micro-organisms involves a multitude of interrelated micro-organism and host factors that vary among species. Clinicians who understand infectious disease development recognize the importance of biofilms in this complexity.
An infectious disease does not occur every time a pathogen colonizes the body. Before causing disease, the bacteria must be able to adhere to and colonize the host’s tissues and reproduce successfully while remaining fit and overcoming the host’s defenses. A minimum number of bacteria must be present to express a coordinated sequence of genetic events resulting in infectious disease. DNA comprises instructions that dictate how bacterial pathogens evade antimicrobials and the immune system, change their virulence, and cause infection — the formation of a biofilm is one method micro-organisms use to subvert antimicrobials and the host’s immune system and enable survival in the human body.
Biofilms attach to wet or moist surfaces — a successful strategy micro-organisms have developed for their survival. Biofilm disease is difficult to eradicate, is a source of many recalcitrant infections, and resembles a multicellular organism or a community structure with many common goals for survival. In addition to those addressed in healthcare, bacterial cells in food, water, and industrial and environmental ecosystems are predominantly organized in specialized biofilms that have significantly different phenotypic properties from free-floating bacteria of the same species. The micro-organisms in the biofilm may remain dormant for years and may periodically shed bacteria; this phenomenon and an injury that dislodges the bacteria may release enough micro-organisms to cause an infection.
Treatment of an infectious disease has typically depended on the microbiology laboratory to describe planktonic, freely suspended, rapidly growing micro-organisms based on their growth characteristics in culture media and their sensitivities to antibiotics. However, the laboratory environment is not representative of how micro-organisms appear and respond in their natural environment in a host; hence, conventional cultures often do not reveal all the organisms present. In addition, hundreds of bacteria in a biofilm may grow as a single colony.
Biofilms comprise slow-growing, difficult- or impossible-to-culture micro-organisms. Easily grown, rapidly multiplying, contaminating, and colonizing micro-organisms may overshadow biofilm micro-organisms, making them difficult to recognize or easily overlooked. Thus, the quantity or variety of organisms present may be underestimated. Sonication of the biofilm will disrupt the integrity of the biofilm and release the micro-organisms, providing an opportunity for culture and treatment by conventional methods.
Treatment of biofilm micro-organisms can be difficult and frustrating. Biofilm infections tend to persist on medical devices, dead bone, and necrotic tissues despite antibiotics, antiseptics, and the host’s immune response. If no biofilm is present, these sites may act as sites of adhesion, the early stage of biofilm development. Biofilm resistance to antimicrobials or the failure to kill or suppress micro-organisms protected in the biofilm may be an underlying dynamic in chronic osteomyelitis, chronic wounds, and the resistance of exposed tendon to coverage with granulation tissue or skin grafting. As a result, biofilms may help explain why some wound care treatments are successful and others are not. Much research is needed in this area.
Conclusion
Biofilms help explain why infections respond well to removal of a medical device; why chronic quiescent osteomyelitis, cellulitis in the calf, and other recurring infections become active infections; why wounds should be healing but are not; why infected bone and wounds respond well to debridement; and why skin ulcers, wounds, burns, and other necrotic tissues respond well to frequent maintenance debridement.
Biofilms, persisters, and other unculturable (and therefore, unrecognized) pathogens underscore the inadequacy of sampling and culturing methods presently in use. Experiences with biofilms and persisters suggest the need for a culture-independent approach for pathogen identification. Current culture methods to demonstrate presence of infectious disease and antibiotic treatment based on sensitivities from these cultures may soon become obsolete. Along with other unrecognized pathogens, biofilms provide an opportunity to reconsider commonly held beliefs and assumptions regarding infection and offer new possibilities for diagnosis and treatment. The ramifications of biofilms can be widespread. To this end, clinicians should not only maintain a healthy skepticism regarding seemingly unexplainable phenomena, but also consider all possibilities, no matter how unorthodox.
Recurring and Antimicrobial-Resistant Infections: Considering the Potential Role of Biofilms in Clinical Practice
author: Donald E. Saye, DPM
A biofilm colony is a complex, structured, interdependent community of micro-organisms enclosed in a self-produced polymeric matrix (the biofilm, frequently referred to as glycocalyx or slime). Biofilm is adherent to inert and living surfaces that have sufficient moisture and/or nutrients to sustain its survival.1,2 Like other infections, the biofilm colony may be a single species or a mixture of species of bacteria and/or fungi and may be different strains of the same species.3-7
Biofilm formation is not uncommon or limited to a small number of micro-organisms or tissues.1,8,9 The Centers for Disease Control and Prevention (CDC) has suggested that biofilms account for 80% of human infections.10 Alam et al11 screened 111 cultures of pus, exudate, joint aspirate, and blood obtained aseptically from cases of osteomyelitis and septic arthritis. Glycocalyx was found in 76.3% of isolates of Staphylococcus aureus, 57.1% of S. epidermidis, 50% of Pseudomonas aeruginosa, and 75% of Escherichia coli. Gristina et al12 examined tissues from biomaterials and prosthesis-related infection in 25 surgical patients in a general hospital setting and found that 76% of the causative bacteria grew in biofilms; 17 of these infections were associated with orthopaedic prostheses, 59% of which were in biofilms. However, organisms in biofilms do not always produce an infectious disease and are not always harmful. Current knowledge of biofilm development, resistance of micro-organisms to antibiotics and biocides, and issues related to culturing micro-organisms in biofilms is summarized to help clinicians improve clinical outcomes in soft tissue and bone infections and the treatment of wounds. A glossary of relevant terms (see “Glossary of Terms”) has been provided.
Biofilm Development
Biofilms form on wet or moist surfaces. Biofilm formation begins immediately upon micro-organism contact with biologic tissue or a medical device4,13–21 (see Figure 1).
Biologic tissue. Initially, organic molecules in tissue fluids form a layer on the tissues or medical device called a conditioning film. The different strains or species of micro-organisms in the immediate vicinity co-aggregate22; subsequently, cell-to-cell adhesion to the conditioning film occurs.13,23–25 With continued adhesion of micro-organisms, a multilayered colony of cells is formed. The colony of micro-organisms anchors firmly and is surrounded with a self-produced, glue-like slime matrix, comprised primarily of exopolysaccharide and some lipids, proteins, and nucleic acids.26–33 Once the colony is anchored, the process becomes irreversible.
The biofilm has a rough, irregular surface that contains many individual colonies of non-uniform, mushroom-shaped or finger-like columns surrounded by fluid-filled channels in which nutrients, enzymes, and waste products circulate.34 Biofilms produced under different conditions differ in their cellular morphology and matrix content.35 The biofilm’s strength of attachment depends on its adhesion to the conditioning film.13,36 Human blood has been shown to enhance development of Gram-positive and Gram-negative bacterial biofilms37; heparin has been shown to promote S. aureus biofilm formation.38
A mature biofilm may take a few hours or several weeks to fully develop. In one study,39 a methicillin-resistant S. aureus biofilm was found to be six cells thick and covered 10% of the surface of a silastic catheter after 2 hours. The biofilm may entrap minerals — mineral build-up is associated with catheter blockage.40
Biofilm colonies form on traumatized or compromised living tissues and nonviable necrotic tissues such as burns,8 wounds and skin ulcers,41,42 and exposed or damaged tendon.43 Impetigo and furuncles have been identified as ideal surfaces for biofilm formation by contaminating and colonizing bacteria.44 Acute and chronic otitis media, chronic tonsillitis, osteomyelitis, bone fragments or sequestra, and exposed bone are susceptible tissues for biofilm formation.42,45,46 Biofilms are found on heart valves, dental enamel, intestinal mucosa,1 between toes and in armpits,47 and are associated with rheumatoid arthritis48 and genitourinary disease.49,50
Medical devices. Because metal plates or screws, artificial joints, indwelling catheters, internal fixation devices, sutures,8,51 and other internal medical devices may be wet or moist surfaces, they are subject to biofilm formation. Biofilms also form on bone cement, even in the presence of antibiotics, including gentamicin52–55; they use these surfaces as a foundation to spread into adjacent tissues and form new colonies of biofilm-protected micro-organisms.12
The effect of strains. Biofilm formation is strain dependent.56,57 Different strains of the same bacteria may develop biofilms of different consistencies. Generally, older biofilms are more developed, provide more protection, and their micro-organisms are more resistant to biocides, antibacterials, and conventional culturing than younger colonies.13,58
Gene expression. Gene expression plays an important role in biofilm production, pathogenicity, and virulence.59–62 High population or critical cell population density-dependent processes known as quorum sensing provide bacteria the ability to communicate, coordinate, and respond to gene expression via signaling molecules once a threshold population density has been reached.63,64 Bacteria produce and detect signaling molecules (autoinducers) and use them to communicate cell-to-cell and coordinate gene expression (behavior). When bacteria multiply to a high population density (a quorum) and produce enough autoinducer (reach and sense a threshold level), the group responds by coordinating its gene expression with a population-wide gene expression, coordinating the behavior of the entire community of bacteria.65 For example, bacteria may colonize a wound, but they do not become a pathogenic-causing disease until they reach a certain population density such as 105 bacteria per gram of tissue. Micro-organisms use quorum sensing for diverse genetic cellular processes, including biofilm formation.57,64,66
Survival. Micro-organisms within the biofilm may be in a low metabolic state but remain fit and able to survive under stress on a minimal amount of nutrients. An anerobic layer of bacteria may develop beneath the aerobic layer where oxygen levels are low enough to sustain their survival.
Infection. Bacteria in biofilms are commonly responsible for recurring infections after repeated trials of antibiotics.1,67 The micro-organisms may be slow to produce clinical symptoms and may remain dormant for weeks or years before causing local or systemic signs and symptoms of infection. Because the biofilm is a dynamic environment,30,32,68,69 the integrity of part or all of the biofilm may fail at any time. The micro-organisms no longer within the biofilm may quickly multiply and disperse, causing rapid increases in bacterial counts and random showers of bacteria.70,71
Detachment or separation and dispersal of bacteria from the biofilm, such as after an injury, can act as a nidus of infection.72,73 The micro-organisms that are now planktonic, or free-floating, may cause a bacteremia or a chronic recurring infection such as osteomyelitis, cellulitis, sinusitis, or urinary tract infections. Biofilm colonies are often polymicrobial — the same bacteria may not always cause the recurrent infection.
Biofilm Resistance
Biofilms are complex and depending on a variety of factors, including bacterial strain and dosage of the antibiotic, may decrease or may have little or no impact on the effectiveness of antimicrobials.74–83 Appropriate antibiotics act on the bacteria outside the biofilm while the same species of bacteria inside the biofilm are effectively protected from most antimicrobials and the host’s defense mechanisms.
MBC concentration. Bacteria inside the biofilm have a much higher minimum bactericidal concentration (MBC) than the same strain of bacteria outside the biofilm.72,77,84,85 Bacteria within a biofilm may require levels of antibiotics up to 5,000 times the MBC to kill all of their biofilm-protected bacteria compared to MBC levels that kill free-floating cells of the same strain.73 In a microbiological survey of automated water systems, Dreeszen86 reported bacteria in biofilms 3,000 times more resistant to free chlorine than the planktonic bacteria. This may overstate the clinical problem since most human infections are treated successfully with antimicrobials. However, achievable safe therapeutic levels of most antibiotics have been shown to be ineffective in killing most biofilm-protected bacteria.8,81,87
The mechanism of resistance is complex and remains unclear but is known to be multifactorial and varies with the species and the strain of the micro-organism. Resistance appears to depend on multicellular synergistic behavior,88 the physiological characteristics of the biofilm itself, the age of the biofilm, altered physiology of cells within the biofilm, and phenotypic changes in the cells within the biofilm.4,9,89–91
Synergistic behavior. Rather than conforming to individual, single-species bacterial behavior, micro-organisms in a biofilm, whether or not mixed species, communicate between and among the same and different species by cell-to-cell signaling, interacting with each other and their environment, sharing resources, and exhibiting multicellular synergistic behavior with common goals similar to a community.92–96 One of the goals of these communities is to lessen the effects of biocides and antimicrobials. This behavior cannot be achieved by individual single-species micro-organisms.32,92–94,97–101
Charge and age. Other physiological characteristics of the biofilm contribute to resistance. The biofilm has a negative charge and may restrict diffusion of positive-charged antibiotics such as aminoglycosides. In general, older biofilms are more developed, thicker, and more viscous.58,102–104 The biofilm may act as a mechanical barrier, resisting penetration or slowing the rate of diffusion of the biocide or antimicrobial; hence, diminishing its effect.105 Only those bacteria found in the outer layer of the biofilm may be exposed to the antimicrobials and antigens. In addition, antibiotic penetration is agent- and organism-specific.
Altered physiology. The biofilm may dilute, bind, or entrap all or part of the antimicrobial, preventing therapeutic levels of antibiotics, antibodies, or phagocytes from reaching the bacteria within the biofilm,102,106–113 limiting therapy effectiveness. Slow diffusion through the biofilm allows more time for the bacteria within the biofilm to provide a community-wide defense response to weaken the effect of the incoming antimicrobials.114
When the antimicrobials are able to penetrate the biofilm and kill the bacteria within, a few resistant strains may survive. These surviving bacteria (persisters) may be intracellular and are resistant to further antibiotic treatment.115,116 When antibiotic therapy is discontinued, the persisters reform the biofilm.
Growth rate. Bacteria in biofilms are associated with slow growth rates,117 especially bacteria in the deeper layers of the biofilm where nutrients may have difficulty penetrating the biofilm and waste product excretion may be slow.1,77,118–120 Many antibiotics (eg, cephalosporins) are less effective against slowly multiplying bacteria.
Colony size. Biofilm colonies are generally too large for phagocytes to engulf them. The biofilm may resist penetration by the phagocytes, reducing their effectiveness. Chemotactic activities of phagocytes may be inhibited by the biofilm.8,52,113,121,122
Gene expression. Gene expression plays an important role in pathogenicity and virulence of micro-organisms in the biofilm.123 The phenotypic changes that occur in the micro-organisms within the biofilm make them resistant to antimicrobial treatment and to the host’s immune response.89,124,125 Micro-organisms in biofilms often will express more virulent phenotypes than the same planktonic strain.59,123,126,127 The bacterial cell has a small number of target sites for antibiotics. It is theorized that some cells in the biofilm, using different genes than the planktonic bacteria, phenotypically alter these target sites to protect themselves.124,128–131 Quorum-sensing and sigma factor systems that signal bacteria to change their biochemistry regulate many of these gene expressions. Biocides have a much larger number of target sites, making it difficult for micro-organisms to develop resistance to such compounds; however, bacteria in the biofilm can and do resist biocides.
Biofilm Cultures
Micro-organisms grow almost everywhere but fewer than 10% can be grown outside their environment in the laboratory.132–137 Accurate identification and determination of micro-organism antibiotic sensitivities are important for the selection of appropriate therapy. However, micro-organisms within biofilm resist conventional culturing methods.8,73,138,139 The same strain of micro-organism outside the biofilm and micro-organisms released when the biofilm is disrupted lose their protection and may be cultured using conventional culturing methods.
Biofilm colonies are dynamic and frequently changing.30 A biofilm colony containing many bacteria may detach intact, sometimes separated by an injury, and grow as a single colony on or in culture media.74 Because these colonies may be slow growing,117 the cultures may be discarded before the organisms have been identified. When biofilm colonies are cultured, contaminating or colonizing bacteria may dominate the culture and the pathogenic organism, if grown at all, may never be identified.12
The micro-organisms that separate from the biofilm and are identified by conventional culturing methods may not be representative of the types, numbers, or pathogenicity of bacteria within the biofilm.8,140 Instead of identifying the pathogenic bacteria in the biofilm causing the infection, conventional cultures may identify the non-pathogenic planktonic bacteria; therefore, failure to disrupt the biofilm may result in a falsely sterile culture or the recovery of the non-pathogenic planktonic bacteria colonizing or contaminating the tissues. Sensitivity reports for these bacteria may lead to a false clinical interpretation. Consequently, long-established conventional methods of collecting micro-organisms from bone, blood, joint effusion, swabs, or soft tissue samples in sufficient numbers to be identified in cultures may be thwarted by the properties of the biofilm.12
Ultrasonic oscillation (sonication) of biofilm culture specimens using low-energy, high frequency sound waves has been shown to disrupt the biofilm.104,141,142 Once the biofilm is disrupted or the micro-organisms leave the biofilm, the micro-organisms revert back to their original phenotype and can be identified using conventional culture techniques. Another method to identify bacteria is a culture-based independent approach to detect and identify micro-organisms in a biofilm-protected environment.135,136,143,144 These non-conventional methods are not readily available to the clinician.145,146
Treatment
The treatment of biofilm-related infections is complex and beyond the scope of this paper. In addition, definitive treatment for biofilm infections for the most part remains in the sphere of research studies that have yet to reach clinical practice. Much of the data come from animal or laboratory models or industrial use and vary widely in design. Because research studies are performed under ideal conditions that are much different from the conditions encountered in the human body, they are not necessarily clinically useful. Furthermore, the biofilm and the bacteria in the biofilm are dynamic and constantly changing. Because of the complexity of this issue, the treatment of biofilm infections remains poorly understood and under investigation.
Discussion
Infection is rare considering that on a daily basis the human body coexists in a symbiotic relationship with 1014 micro-organisms from a countless number of vectors.147 The development of an infectious disease and the virulence of the micro-organisms involves a multitude of interrelated micro-organism and host factors that vary among species. Clinicians who understand infectious disease development recognize the importance of biofilms in this complexity.
An infectious disease does not occur every time a pathogen colonizes the body. Before causing disease, the bacteria must be able to adhere to and colonize the host’s tissues and reproduce successfully while remaining fit and overcoming the host’s defenses. A minimum number of bacteria must be present to express a coordinated sequence of genetic events resulting in infectious disease. DNA comprises instructions that dictate how bacterial pathogens evade antimicrobials and the immune system, change their virulence, and cause infection — the formation of a biofilm is one method micro-organisms use to subvert antimicrobials and the host’s immune system and enable survival in the human body.
Biofilms attach to wet or moist surfaces — a successful strategy micro-organisms have developed for their survival. Biofilm disease is difficult to eradicate, is a source of many recalcitrant infections, and resembles a multicellular organism or a community structure with many common goals for survival. In addition to those addressed in healthcare, bacterial cells in food, water, and industrial and environmental ecosystems are predominantly organized in specialized biofilms that have significantly different phenotypic properties from free-floating bacteria of the same species. The micro-organisms in the biofilm may remain dormant for years and may periodically shed bacteria; this phenomenon and an injury that dislodges the bacteria may release enough micro-organisms to cause an infection.
Treatment of an infectious disease has typically depended on the microbiology laboratory to describe planktonic, freely suspended, rapidly growing micro-organisms based on their growth characteristics in culture media and their sensitivities to antibiotics. However, the laboratory environment is not representative of how micro-organisms appear and respond in their natural environment in a host; hence, conventional cultures often do not reveal all the organisms present. In addition, hundreds of bacteria in a biofilm may grow as a single colony.
Biofilms comprise slow-growing, difficult- or impossible-to-culture micro-organisms. Easily grown, rapidly multiplying, contaminating, and colonizing micro-organisms may overshadow biofilm micro-organisms, making them difficult to recognize or easily overlooked. Thus, the quantity or variety of organisms present may be underestimated. Sonication of the biofilm will disrupt the integrity of the biofilm and release the micro-organisms, providing an opportunity for culture and treatment by conventional methods.
Treatment of biofilm micro-organisms can be difficult and frustrating. Biofilm infections tend to persist on medical devices, dead bone, and necrotic tissues despite antibiotics, antiseptics, and the host’s immune response. If no biofilm is present, these sites may act as sites of adhesion, the early stage of biofilm development. Biofilm resistance to antimicrobials or the failure to kill or suppress micro-organisms protected in the biofilm may be an underlying dynamic in chronic osteomyelitis, chronic wounds, and the resistance of exposed tendon to coverage with granulation tissue or skin grafting. As a result, biofilms may help explain why some wound care treatments are successful and others are not. Much research is needed in this area.
Conclusion
Biofilms help explain why infections respond well to removal of a medical device; why chronic quiescent osteomyelitis, cellulitis in the calf, and other recurring infections become active infections; why wounds should be healing but are not; why infected bone and wounds respond well to debridement; and why skin ulcers, wounds, burns, and other necrotic tissues respond well to frequent maintenance debridement.
Biofilms, persisters, and other unculturable (and therefore, unrecognized) pathogens underscore the inadequacy of sampling and culturing methods presently in use. Experiences with biofilms and persisters suggest the need for a culture-independent approach for pathogen identification. Current culture methods to demonstrate presence of infectious disease and antibiotic treatment based on sensitivities from these cultures may soon become obsolete. Along with other unrecognized pathogens, biofilms provide an opportunity to reconsider commonly held beliefs and assumptions regarding infection and offer new possibilities for diagnosis and treatment. The ramifications of biofilms can be widespread. To this end, clinicians should not only maintain a healthy skepticism regarding seemingly unexplainable phenomena, but also consider all possibilities, no matter how unorthodox.